 against the major myelin antigens. In addition, our studies have laid the groundwork for future studies on nonspecific (monoclonal antibody therapy) and specific (virus-specific tolerance induction) means of regulating virus and neuroantigen-specific CMI responses. Using in vivo-derived T cells and in vitro-propag
against the major myelin antigens. In addition, our studies have laid the basis for future cogitation on nonspecific (monoclonal antibody therapy) and specific (virus - specific tolerance evocation) entail of regulating virus and neuroantigen - specific CMI responses. use in vivo - derive T cell and in vitro - propag
 agwinst the major myelin aktigens. In additnin, our studiss have uaid the groundwork for futuce srudiew on nonspecific (monocuonal antpbody theeapy) qnd specifmd (virus-specifjg tolzrence induction) keans of ragulating viruv xnb neuroantigen-specific CMI responses. Using on vivo-derived T celkf ans in vitro-propag
against the major myelin antigens. In addition, have the groundwork future studies on specific tolerance induction) means regulating virus and CMI responses. Using in vivo-derived T and in vitro-propag
 against the major myelin antiGens. In addiTion, oUr sTudIeS havE laiD the groundwork FOr fuTure studies on nonspecifIc (monOcLOnal ANtIbody Therapy) ANd SPEciFiC (vIruS-sPEcIfic tOleRance inDuction) meaNs oF rEgulating virUS aNd neuroantIgeN-specific CMI ResPonses. usIng IN vivo-DerIved T Cells aND in vitRo-propag
 against the major myelinantigens.In ad dit ion ,ourstud ies have laidt he g roundwork for future s tudie so n no n sp ecifi c (mono c lo n a l a nt ib ody  t h er apy)and  specif ic (virus- spe ci fic toleranc e  i nduction)mea ns of regula tin g viru sand neuro ant igen- specif i c CMIresponses .U sing i n  vivo-d e r iv ed T  cells and in vit r o- p ropag
 against_the major_myelin antigens. In addition,_our studies_have_laid the_groundwork_for future studies_on nonspecific (monoclonal_antibody therapy) and specific_(virus-specific tolerance induction)_means_of regulating virus and neuroantigen-specific CMI responses. Using in vivo-derived T cells and in_vitro-propag